ARCHIVES

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

This article is from The Cancer Letter archive.

Vol. 27 No. 27 | July 6, 2001

Download PDF Visit The Full Archive

Related Articles

Brachytherapy Prevents Endometrial Cancer Return

June 27, 2008

30 Years After Reports On Smoking,, Feds Given Low Grade On Tobacco Control

January 14, 1994

GAO Study Claiming No Benefit Seen In Adjuvant Breast Cancer Treatment Flawed, NCI Responds

April 21, 1989

Preyer Supported For Chairmanship

January 26, 1979

Reagan Signs 12989 Appropriations Bill; Reauthorization Still Held Up In Congress

September 23, 1988

Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies

October 26, 2001